1H-Imidazole-4-carbaldehyde → HCID 178520741, compound
Reaction equation
[NH2:1][C@H:2]1[CH2:7][CH2:6][C@H:5]([CH2:8][C:9]([NH:11][C@H:12]2[CH2:17][C:16]3[CH:18]=[CH:19][CH:20]=[C:21]([C:22]([OH:24])=[O:23])[C:15]=3[O:14][B:13]2[OH:25])=[O:10])[CH2:4][CH2:3]1.[NH:26]1[C:30]([CH:31]=O)=[CH:29][N:28]=[CH:27]1>>[NH:26]1[C:30]([CH2:31][NH:1][C@H:2]2[CH2:7][CH2:6][C@H:5]([CH2:8][C:9]([NH:11][C@H:12]3[CH2:17][C:16]4[CH:18]=[CH:19][CH:20]=[C:21]([C:22]([OH:24])=[O:23])[C:15]=4[O:14][B:13]3[OH:25])=[O:10])[CH2:4][CH2:3]2)=[CH:29][N:28]=[CH:27]1Participants
3
Procedure
Prepared from (R)-3-(2-(trans-4-aminocyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid (Example 6) and 1H-imidazole-5-carbaldehyde following the procedure in Example 27. The product was purified using reverse phase HPLC to afford the titled compound. ESI-MS m/z 427 (MH)+.
Workup
- customThe product was purified
Sources & evidence
- ORD record
- ord-e9181789db60454ba23ee574b1acc0ec
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08912169B2
Reaction notes
Loading…